Invivyd

Invivyd is a company listed under the stock ticker IVVD (US).

View the org chart displaying its 20 main executives

Most searched biographies at Invivyd

• Jeremy Gowler, Interim Chief Executive Officer
• Sara Cotter, Director
• Christine Lindenboom, Director

Popular executive movements at Invivyd

• Jeremy Gowler, who was Chief Operating and Commercial Officer, is promoted to Interim Chief Executive Officer  (posted on April 15 2024).
• William Duke has joined the company as Chief Financial Officer  (posted on September 6 2023).
• Sara Cotter has joined the company as Director  (posted on July 28 2023).

Create your alert
to follow the executive moves at Invivyd.

Invivyd has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Invivyd

• Adagio |

Social media about Invivyd

• Invivyd on Wikipedia, Google News & Yahoo Finance
• Invivyd on LinkedIn, Twitter & YouTube

Contact by email its executives including Sara Cotter

Call Invivyd at +1 781...

View the org chart

Register to receive your alert

Report an error